MITA activation by tumor DNA elicits anti-tumor immunity by type I IFN induction and tumor antigen presentation by DCs [32], whereas MITA-mediated inflammation promotes tumorigenesis in an inflammation-induced skin cancer model [70]. The gene discussed is STING1; the disease is skin neoplasm.